Bernard L. Kasten is Director at ENZO BIOCHEM INC (ENZ). They have made 5 open-market trades across 2 companies since 2010, most recently 2016-03-11.
CIK 0000316253
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $100K since 2010, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENZ | SELL | 2016-03-10 | 2016-03-18 | $3.47 | $65K | +1.8% | +11.0% | +25.5% |
| ENZ | SELL | 2016-01-21 | 2016-03-18 | $4.00 | $335K | +1.8% | +11.0% | +25.5% |
| ENZ | SELL | 2014-10-23 | 2014-11-13 | $4.94 | $78K | +5.5% | +6.6% | +6.6% |
| CBLI | BUY | 2011-08-15 | 2011-08-15 | $2.59 | $26K | N/A | N/A | N/A |
| CBLI | BUY | 2010-11-18 | 2010-11-22 | $6.14 | $74K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.